Breaking News, Promotions & Moves

Mallinckrodt Names Christiana Stamoulis President and CFO

She succeeds Bryan Reasons, who has decided to leave the company to pursue other interests.

By: Rachel Klemovitch

Assistant Editor

Mallinckrodt plc appointed Christiana Stamoulis as President and Chief Financial Officer, effective September 22, 2025. Stamoulis, currently the EVP and Chief Financial Officer of Incyte, will succeed Bryan Reasons, who has decided to leave the company to pursue other interests. Stamoulis joins Mallinckrodt from Incyte, a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. In addition to overseeing the finance organization, she w...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters